Have a look at ISIS 3-month chart and track price movement 2-months before trial results announced. ISIS has similar run-up and tribulation before the big 30% pop up on positive trial news yesterday:
1. 4/3 - $16.29 ; 4/15 - $18.38; 4/29- $22.61 Then the 22% drop
2. 5/9 - $18.50; 5/22 - $20.39; 5/29 - $21.91; 6/5 - $20.91; (6/13 – 23.63; 6/20 - $20.75 *14% drop*); 6/23- $21.96
3. Gap up 30% 6/24 to $28.42 yesterday on good trial results.
The ISIS investors had to endure the 22% drop $22.61 to $18.50 about like MNKD ($7.60 to $5.95) along with more bumpy rides to follow and ultimately hitting $28.42 6-weeks later. Looking above, could one have guessed when the data is good or bad the prior 8-weeks of actual news based on the stock price movement? The six weeks prior price range was $18.50 to 28.42 (54% delta). If we start the clock now and say MNKD bottom could be $5.75 and apply the 54% gains, we could be looking at $8.85 with good news (bad comparison but just for fun). I am, however, optimistic and believe we can break $10.00 with good news on 8/15.
ACAD was a little more stable and went from $8.00 to $13.00 (63% bump) overnight with good trial results announcement. Not out of the question for MNKD. Based on the above and other stocks I have tracked in the past. I don’t believe one can predict data outcome with biotech stock big volatility swings.
As long as MNKD have good results, and I believe they will, I think the stock price will take care of itself and will do well. Board opinion?
